Close

UPDATE: Baird Downgrades Immunovant (IMVT) to Neutral

August 3, 2021 4:13 AM EDT Send to a Friend
(Updated - August 3, 2021 9:08 AM EDT)

Baird analyst Brian Skorney downgraded Immunovant (NASDAQ: IMVT) from Outperform to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login